176
Participants
Start Date
March 27, 2019
Primary Completion Date
February 22, 2022
Study Completion Date
April 14, 2022
Subcutaneous elamipretide through the elamipretide delivery system
Subjects will be randomized in a 2:1 ratio to receive either elamipretide or placebo through the elamipretide delivery system. Subjects will dose daily for up to 48 weeks.
Subcutaneos placebo through the elamipretide delivery system
Subjects will be randomized in a 2:1 ratio to receive either elamipretide or placebo through the elamipretide delivery system. Subjects will dose daily for up to 48 weeks.
Retina Associates of Western New York, Rochester
The Retina Care Center, Baltimore
Cumberland valley retina consultants, Hagerstown
University of Virginia, Department of Ophthalmology, Charlottesville
Duke Eye center, Durham
Southeast Retina Center, PC, Augusta
Bascom Palmer Eye Institute, Miami
MedEye Associates, Miami
Bascom Palmer Eye Institute, Palm Beach Gardens
Center for Retina and Macular Disease, Winter Haven
Tennessee Retina, Nashville
Sterling Research Group, Cincinnati
Specialty Eye Institute, Jackson
Black Hills Regional Eye Institute, Rapid City
Oklahoma University Health Sciences Center, Oklahoma City
Ophthalmology Associates, Fort Worth
Texas Retina Associates, Fort Worth
Retina Consultants of Houston, PA, Houston
Retina Consultants of Houston, Katy
Valley Retina Institute, PA, McAllen
Retina Research Center, PLLC, Austin
Retina Research Institute of Texas, Abilene
Retinal Research Institute, LLC, Phoenix
Arizona Retina & Vitreous Consultants, Phoenix
Retinal Research Institute, LLC, Phoenix
Global Retina Institute, Scottsdale
Associated Retina Consultants, Ltd., Peoria
Retina-Vitreous Associates Medical Group, Beverly Hills
Retina Institute of California Medical Group, Palm Desert
California Retina Consultants, Santa Barbara
California Retina Consultants, Bakersfield
California Retina Consultants, Santa Maria
Retina Northwest, P.C, Portland
Ophthalmic Consultants of Boston, Boston
New England Retina Consultants, Springfield
Retina Center of New Jersey LLC, Bloomfield
New Jersey Retina, Teaneck
Stealth BioTherapeutics Inc.
INDUSTRY